The CO2-SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant-induced arthritis in rats

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 149, Issue 2, 2008, Pages 251-258

  Singh, M ^a   Hodges, L D ^a   Wright, P F A ^a   Cheah, D M Y ^a   Wynne, P M ^b   Kalafatis, N ^a   Macrides, T A ^a  

^a RMIT UNIVERSITY   (Australia)

^b SGE Analytical Science Pty Ltd   (Australia)

Author keywords

Adjuvant arthritis; Anti inflammatory; Perna canaliculus; 3 PUFA

Indexed keywords

CERULOPLASMIN OXIDASE; FATTY ACID; LIPID; NATURAL PRODUCT; OXIDOREDUCTASE; PERNA CANALICULUS EXTRACT; PIROXICAM; TARTARIC ACID; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CARBON DIOXIDE; LEUKOTRIENE; TISSUE EXTRACT;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL MODEL; MALE; MOLLUSC; NONHUMAN; PAW EDEMA; PERNA CANALICULUS; PRIORITY JOURNAL; RAT; SPLEEN; SUPERCRITICAL FLUID; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; ARTHRITIS; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; HUMAN; LONG EVANS RAT; METABOLISM; METHODOLOGY; PERNA; SUPERCRITICAL FLUID CHROMATOGRAPHY;

PERNA CANALICULUS; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CARBON DIOXIDE; CELLS, CULTURED; CHROMATOGRAPHY, SUPERCRITICAL FLUID; FATTY ACIDS, NONESTERIFIED; HUMANS; LEUKOTRIENES; PERNA; PIROXICAM; RATS; RATS, LONG-EVANS; TISSUE EXTRACTS;

EID: 37349048927     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2007.09.015     Document Type: Article

References (27)

1. Billingham M.E.J. Models of arthritis and the search for anti-arthritic drugs. Pharmacol. Ther. 21 (1983) 389-428
2. Celotti F., and Laufer S. Anti-inflammatory drugs: new multitarget compounds to face an old problem: the dual inhibition concept. Pharmacol. Res. 43 (2001) 429-436
3. Charlier C., and Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur. J. Med. Chem. 38 (2003) 645-659
4. Cho U.S., Park E.Y., Dong M.S., Park B.S., Kim K., and Kim K.H. Tight-binding inhibition by α-naphthoflavone of human cytochrome P450 1A2. Biochim. Biophys. Acta 1648 (2003) 195-202
5. Claria J., and Romano M. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr. Pharm. Des. 11 (2005) 3431-3447
6. Fowler B.A., Kleinow K.M., Squibb K.S., Lucier G.W., and Hayes A.W. Organelles as tools in toxicology. In: Hayes A.W. (Ed). Principles and Methods of Toxicology (1996), Raven Press, New York 1201-1230
7. Freneaux E., Fromenty B., Berson A., Labbe G., Degott C., Letteron P., Larrey D., and Pessayre D. Steroselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids. J. Pharmocol. Exp. Ther. 255 (1990) 529-535
8. Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 56 (2002) 388-396
9. Ivens I.A., Loser E., Rinke M., Schmidt U., and Mohr U. Subchronic toxicity of 2, 3, 7, 8-tetrabromodibenzo-p-dioxin in rats. Toxicology 83 (1993) 181-201
10. Jain K.S., Kathiravan M.K., Somani R.S., and Shishoo C.J. The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem. 15 (2007) 4674-4699
11. Jala V.R., and Haribabu B. Leukotrienes and athersclerosis: new roles for old mediators. Trends Immunol. 25 (2004) 315-322
12. Lake B.G. Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In: Snell K., and Mullock B. (Eds). Biochemical Toxicology: A Practical approach (1987), IRL Press, Oxford, England 183-214
13. Lee D.M., and Weinblatt M.E. Rheumatoid arthritis. Lancet 358 (2001) 903-911
14. Markwell M.K., Haas S.M., Bieber L.L., and Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87 (1978) 206-210
15. McColl S.R., Cleland L.G., Whitehouse M.W., and Vernon-Roberts B. Effect of dietary polyunsaturated fatty acid (PUFA) supplementation on adjuvant induced polyarthritis in rats. J. Rheumatol. 14 (1987) 197-201
16. McGarry J.D., Leatherman G.F., and Foster D.W. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J. Biol. Chem. 253 (1978) 4128-4136
17. McPhee S., Kalafatis N., Wright P.F.A., and Macrides T.A. The marine oil Lyprinol®, is a substrate for the 5-lipoxygenase enzyme in porcine neutrophils. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 9 (2001) 95
18. McPhee S., Hodges L.D., Wright P.F.A., Wynne P.M., Kalafatis N., Harney D.W., and Macrides T.A. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp. Biochem. Physiol. B 146 (2007) 346-356
19. Rainsford K.D. Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?. Agents Actions 12 (1982) 452-458
20. Schosinsky K.H., Lehmann H.P., and Beeler M.F. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin. Chem. 20 (1974) 1556-1563
21. Stamp L.K., James M.J., and Cleland L.G. Diet and rheumatoid arthritis: a review of the literature. Semin. Arthritis Rheum. 35 (2005) 77-94
22. Tagliati C.A., Kimura E., Nothenberg M.S., Santos S.R.J.C., and Oga S. Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats. Gen. Pharmacol. 33 (1999) 67-71
23. Travlos G.S., Morris R.W., Elwell M.R., Duke A., Rosenblum S., and Thompson M.B. Frequency and relationships of clinical chemistry and liver and kidney histopathology findings in 13-week toxicity studies in rats. Toxicology 107 (1996) 17-29
24. Treschow A.P., Hodges L.D., Wright P.F.A., Wynne P.M., Kalafatis N., and Macrides T.A. Novel anti-inflammatory ω-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp. Biochem. Physiol. B 147 (2007) 645-656
25. Walz D.T., DiMartino M.J., and Misher A. Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters. J. Pharmacol. Exp. Ther. 178 (1971) 223-231
26. Whitehouse M.W., and Beck F.J. Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review. Drug Metab. Dispos. 1 (1973) 251-255
27. Whitehouse M.W., Macrides T.A., Kalafatis N., Betts W.H., Haynes D.R., and Broadbent J. Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel. Inflammopharmacology 5 (1997) 237-246